Drug Utilization Evaluation of Antibiotics at a Tertiary Care Hospital by Sanoj, Panicker
DRUG UTILIZATION EVALUATION OF ANTIBIOTICS AT A
TERTIARY CARE HOSPITAL
A Dissertation submitted to
THE TAMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY,
CHENNAI – 600 032
In partial fulfillment of the requirements for the award of the Degree of
MASTER OF PHARMACY
IN
BRANCH –VII - PHARMACY PRACTICE
Submitted by
Mr. SANOJ PANICKER
REGISTRATION No.261440117
Under the guidance of
Mrs. CHITRA.B, M.Pharm., (Ph.D).,
Department of Pharmacy Practice
COLLEGE OF PHARMACY
SRI RAMAKRISHNA INSTITUTE OF PARAMEDICAL SCIENCES
COIMBATORE - 641 044.
OCTOBER - 2016
CERTIFICATE
This is to certify that the M.Pharm Dissertation entitled
“Drug Utilization Evaluation of Antibiotics at a Tertiary Care Hospital”
being submitted to The Tamil Nadu Dr. M.G.R Medical University, Chennai
was carried out by Mr.Sanoj Panicker in the Department of Pharmacy
Practice, College of Pharmacy, Sri Ramakrishna Institute of Paramedical
Sciences, Coimbatore, under my direct supervision and guidance to my
fullest satisfaction.
Mrs. Chitra.B, M.Pharm., (Ph.D).,
Assistant Professor,
                                                    Department of Pharmacy Practice,
College of Pharmacy,
SRIPMS,
Coimbatore- 641 044
Place : Coimbatore
Date  :
CERTIFICATE
This is to certify that the M.Pharm Dissertation entitled
“Drug Utilization Evaluation of Antibiotics at a Tertiary Care Hospital”
being submitted to The Tamil Nadu Dr. M.G.R Medical University, Chennai
was carried out by Mr.Sanoj Panicker in the Department of Pharmacy
Practice, College of Pharmacy, Sri Ramakrishna Institute of Paramedical
Sciences, Coimbatore, under the direct supervision and guidance of
Mrs.Chitra. B, M.Pharm., (Ph.D)., Assistant Professor, Department of
Pharmacy Practice, College of Pharmacy, Sri Ramakrishna Institute of
Paramedical Sciences, Coimbatore.
Dr. S. Sriram, M.Pharm.,Ph.D.,
Professor and Head,
                                                    Department of Pharmacy Practice,
College of Pharmacy,
SRIPMS,
Coimbatore- 641 044
Place : Coimbatore
Date  :
CERTIFICATE
Drug Utilization Evaluation of Antibiotics at a Tertiary Care
Hospital” being submitted to The Tamil Nadu Dr. M.G.R Medical
University, Chennai was carried out by Mr.Sanoj Panicker in the
Department of Pharmacy Practice, College of Pharmacy,  Sri Ramakrishna
Institute of Paramedical Sciences, Coimbatore, under the direct
supervision and guidance of Mrs.Chitra. B, M.Pharm., (Ph.D).,
Assistant Professor and Head Department of Pharmacy Practice, College
of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences,
Coimbatore.
Dr. T. K. Ravi, M. Pharm., Ph.D.,FAGE.,
Principal
             College of Pharmacy,
         SRIPMS,
              Coimbatore- 641 044
Place :  Coimbatore
Date  :

ACKNOWLEDGEMENT
It is my great privilege and pleasure to acknowledge those who helped me
during my project work. To begin with, I lay this work at the feet of the
"God Almighty" whose blessings made me to complete this project successfully.
I submit my humble and grateful acknowledgement to my guide
Mrs.Chitra. B, M.Pharm., (Ph.D)., Associate Professor, Department of
Pharmacy Practice, whose valuable and unique guidance made my work a
remarkable one.
I sincerely thank my co-guide Dr.N.Senthil Vel, M.D. FCCP., who helped
and guided me throughout my work.
It gives great pleasure to record our deep sense of gratitude and
indebtedness to Dr.T.K.Ravi, M.Pharm., Ph.D., FAGE, Principal, College of
Pharmacy, for providing the necessary facilities to carry out this project work.
         My sincere thanks to Dr. S.Sriram, M.Pharm., Ph.D., HOD, Department of
Pharmacy Practice for the constant support and encouragement throughout the
study period.
I find words inadequate to express my deep sense of gratitude and heartfelt
thanks to my beloved teachers Dr. B.Rajalingam M.Pharm., Ph.D.
Assistant Professor and. Dr.A.S. Manjuladevi, M.Pharm., Ph.D.,
Mr.V.Shivashankar, M.Pharm.,  Mr.Thomas Zacharia, M.Pharm.,
Dr. Lakshmi Menon, Pharm D., and Ms.Meri Levy Philip, M.Pharm., Lecturers,
Department of Pharmacy Practice.
It is my privilege and wonderful experience to be a part of this
esteemed institution and owe my sincere thanks to Dr.S. Sukumaran,
M.S.,M.Ch.,FIACS., Dean of Sri Ramakrishna Hospital, Coimbatore.
My respect regard to the beloved Thiru.R.Vijayakumhar, Managing
Trustee, SNR Sons Trust, Coimbatore who had permitted us and provided with the
facilities to execute this work.
I would like to express our sincere thanks to other Teaching and Non-
Teaching Staff of the institution.
I would like to express my profound gratitude to my beloved Parents and
lovely brother who taught me hard work by their own example, and my siblings
who rendered me enormous support during the whole tenure of life to achieve
more.
I  sincerely  thank  my Seniors and Juniors without whose help and
guidance this project would not have been completed.
I thank myclassmates Ashik, Arthipriya, Jesni, Heleena, Pheba, Gilbert,
Tito, Robin, Shelshiya, Ashwin,Hari who lend me a helping hand during the
course of this study.
My sincere thanks to M/s. Saraswathi Computer Centre  for their help in
bringing out this manuscript in a neat manner.
I would also put on record my thanks to all others who directly or
indirectly gave a helping hand to me while carrying out this study.
Abstract
Department of Pharmacy Practice
ABSTRACT
Drug utilization evaluation studies plays an important role in identifying the
prescription pattern among the patients which helps in providing a useful
information for improvement of the appropriate and effective use of antibiotics
and also developing the proper protocols for the use of antibiotic in hospitals. This
was a prospective observational study carried out in general medicine department
over  a  period  of  10  months  enrolling  150  patients.  The  study  was  carried  out  to
assess prescribing pattern, sensitivity pattern, adverse reaction involved and cost
comparison of antibiotics prescribed in 150 patients. Also DDD/ 100bed- days and
ATC of 10 commonly prescribed antibiotics were calculated.  Most commonly
prescribed antibiotics were Piperacillin / tazobactum followed by Ceftriaxone.
During the study period 12 ADR was reported and most of adverse drug reactions
(ADR) was observed in the age group of 61-80 years. The antibiotic sensitivity
pattern was analysed which revealed that Klebsiella pneumonia was highly
sensitive to Amikacin and Imipenem, E. coli was sensitive to Piperacillin/
tazobactum, E. faecalis was sensitive to Piperacillin/ tazobactum, gentamycin and
Ofloxacin and Streptococcus. Aureus was sensitive to Imipenem, Meropenam and
Ceftriaxone. The total cost was Rs. 1945.29±2175.39 for the prescribed antibiotics
whereas for alternate antibiotics the cost was Rs. 1169.63±1282.04, which would
help in minimising the patient’s expenditure.  Clinical pharmacists and Clinicians
need to play vital role in minimizing the antibiotic problems by conducting
continual awareness programs regarding up-to-date prescribing guidelines in the
hospital and also minimizing the antibiotic resistance. Therefore drug utilization
review programme must be carried out to study the rational use of antimicrobials.
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ABBREVIATIONS
ADR Adverse Drug Reaction
ATC Anatomical Therapeutic Classification
AOSD Adult onset Still’s Disease
APTT Active Partial Thromboplastin Time
ADRAC Adverse drug reaction advisory committee
BPI Bacteriologically Proven Infection
BA Bronchial Asthma
COPD Chronic Obstructive Pulmonary disease
CRF Chronic Renal Failure
CVA Cerebrovascular Accident
DUE Drug Utilisation Evaluation
DDD Daily Defined Dose
DI Drug Interaction
DCM Dilated Cardiomyopathy
DM Diabetes Mellitus
EAG Estimated Average Glucose
eGFR Estimated Glomerular Filtration Rate
GGT Gama GlutamylTransferase
GIT Gastrointestinal Tract
GW General Ward
HD Haemodialysis
ICU Intensive Care Unit
INRUD International network for the Rational Use of Drugs
IHD Ischemic Heart Disease
IPC Indian Pharmacopoeia Commission
LRTI Lower Respiratory Tract Infection
ME Medication Error
NHS National Health Service
NSAID Non Steroidal Anti inflammatory Drug
Abbreviations
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OPD Out Patient Department
PCT Procalcitonin
PT Prothrombin Time
PMS Post marketing Surveillance
PPMS Prescription Pattern Monitoring Studies
POM Prescription Only Medicine
RUM Rational Use Of Medicines
STEMI ST Elevated Myocardial Infraction
SHT Systemic Hypertension
SPSS Statistical Package for the Social Services
TSH Thyroid Stimulating Hormone
UV Ultra violet
UTI Urinary Tract Infection
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INTRODUCTION
Antibiotics are powerful and effective drugs in fighting against infectious
diseases caused by bacteria and have been frequently used for decades worldwide
for effective treatment of a variety of bacterial infections. Antibiotics have saved
millions of lives since their first appearance about fifty years ago. 1
Antibiotics are drugs used to treat bacterial infections. Antibiotics have no
effect on viral infections. Originally, an antibiotic was a substance produced by
one microorganism that selectively inhibits the growth of another. Synthetic
antibiotics, usually chemically related to natural antibiotics, have since been
produced that accomplish comparable tasks.
In 1926, Alexander Fleming discovered penicillin, a substance produced
by fungi that appeared able to inhibit bacterial growth. In 1939, Edward Chain and
Howard Florey further studied penicillin and later carried out trials of penicillin on
humans (with what were deemed fatal bacterial infections). Fleming, Florey and
Chain shared the Nobel Prize in 1945 for their  work which ushered in the era of
antibiotics.
 Antimicrobials can be classified based on  :2
 1.  Spectrum of activity
 2.  Effect on bacteria
3.  Mode of action
· Classification according to spectrum of activity
 Depending on the range of bacterial species susceptible to these agents,
antibacterials are classified as broad-spectrum, intermediate-spectrum, and
narrow- spectrum.
1.  Broad spectrum antibacterials are active against both Gram-positive and
Gram-negative organisms.  Examples include: tetracyclines, Phenicols,
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Fluoroquinolones, “third-generation” and “fourth-generation”
Cephalosporins.
 2.  Narrow spectrum antibacterials have limited activity and are primarily
only useful against particular species of microorganisms.  For example,
Glycopeptides and Bacitracin are only effective against Gram-positive
bacteria, whereas Polymixins are usually only effective against Gram
negative bacteria.  Aminoglycosides and Sulfonamides are only effective
against aerobic organisms, while nitroimidazoles are generally only
effective for anaerobes.
· Effect on Bacteria
Because of differences in the mechanisms by which antibiotics affect
bacteria, the clinical use of antibacterials may have very different effects on
bacterial agents, leading to an endpoint of either inactivation or actual death of the
bacteria.
1.  Bactericidal drugs are those that kill target organisms.  Examples of
Bactericidal drugs include Aminoglycosides, Cephalosporins, Penicillins,
and Quinolones.
2.  Bacteriostatic drugs inhibit or delay bacterial growth and replication.
Examples of such include tetracyclines, Sulfonamides, and Macrolides.
Some antibiotics can be both bacteriostatic and bactericidal, depending on
the dose, duration of exposure and the state of the invading bacteria.  For example,
Aminoglycosides, Fluoroquinolones, and Metronidazole exert concentration-
dependent killing characteristics; their rate of killing increases as the drug
concentration increases.
· Mode of Action
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 Different antibiotics have different modes of action, owing to the nature
of their structure and degree of affinity to certain target sites within bacterial cells.
1.  Inhibitors of cell wall synthesis. While the cells of humans and animals do
not have cell walls, this structure is critical for the life and survival of
bacterial species.  A drug that targets cell walls can therefore selectively
kill or inhibit bacterial organisms.  Examples: Penicllins, Cephalosporins,
Bacitracin and Vancomycin.
2.  Inhibitors of cell membrane function. Cell membranes are important
barriers that segregate and regulate the intra- and extracellular flow of
substances. A disruption or damage to this structure could result in leakage
of important solutes essential for the cell’s survival.  Because this structure
is found in both Eukaryotic and Prokaryotic cells, the action of this class of
antibiotic are often poorly selective and can often be toxic for systemic use
in the mammalian host.  Most clinical usage is therefore limited to topical
applications. Examples: Polymixin B and Colistin.
3.  Inhibitors of protein synthesis. Enzymes and cellular structures are
primarily  made  of  proteins.  Protein  synthesis  is  an  essential  process
necessary for the multiplication and survival of all bacterial cells.  Several
types of antibacterial agents target bacterial protein synthesis by binding to
either the 30S or 50S subunits of the intracellular ribosomes. This activity
then results in the disruption of the normal cellular metabolism of the
bacteria, and consequently leads to the death of the organism or the
inhibition of its growth and multiplication.  Examples: Aminoglycosides,
Macrolides, Lincosamides, Streptogramins, Chloramphenicol,
tetracyclines.
4.   Inhibitors  of  nucleic  acid  synthesis.  DNA  and  RNA  are  keys  to  the
replication of all living forms, including bacteria. Some antibiotics work
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by  binding  to  components  involved  in  the  process  of  DNA  or  RNA
synthesis, which causes interference of the normal cellular processes
which will ultimately compromise bacterial multiplication and survival.
Examples: Quinolones, Metronidazole, and Rifampin.
5.  Inhibitors of other metabolic processes. Other antibiotics act on selected
cellular processes essential for the survival of the bacterial pathogens. For
example, both Sulfonamides and Trimethoprim disrupt the Folic acid
pathway, which is a necessary step for bacteria to produce precursors
important  for  DNA  synthesis.   Sulfonamides  target  and  bind  to
dihydropteroate synthase, Trimethophrim inhibit dihydrofolate reductase;
both of these enzymes are essential for the production of folic acid, a
vitamin synthesized by bacteria, but not humans.
CLASSIFICATION OF ANTIBACTERIAL AGENTS
Antibiotics Classification14
Although there are several classification schemes for antibiotics, based on
bacterial spectrum (Broad versus Narrow) or type of activity (Bactericidal vs.
Bacteriostatic), the most useful is based on chemical structure. Antibiotics within
a structural class will generally have similar patterns of effectiveness, toxicity, and
allergic potential.
The main classes of antibiotics are:
· Beta-Lactams
· Penicillins
· Cephalosporins
· Macrolides
· Fluoroquinolones
· Tetracyclines
· Aminoglycosides
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Most commonly used types of antibiotics are: Aminoglycosides,
Penicillins, Fluoroquinolones, Cephalosporins, Macrolides, and Tetracyclines.
While each class is composed of multiple drugs, each drug is unique in some way.
Penicillins
The penicillins are the oldest class of antibiotics. Penicillins have a
common chemical structure which they share with the Cephalosporins.
Penicillins are generally bactericidal, inhibiting formation of the bacterial
cell wall. Penicillins are used to treat Skin infections, Dental infections, Ear
infections, Respiratory tract infections, Urinary tract infections, Gonorrhea.
There are four types of penicillins:
· The natural penicillins are based on the original penicillin-G structure.
Penicillin-G types are effective against gram-positive strains of
Streptococci, Staphylococci, and some gram-negative bacteria such as
meningococcus.
· Penicillinase-resistant penicillins, notably methicillin and oxacillin, are
active even in the presence of the bacterial enzyme that inactivates most
natural penicillins.
· Aminopenicillins such as Ampicillin and Amoxicillin have an extended
spectrum of action compared with the natural penicillins. Extended
spectrum penicillins are effective against a wider range of bacteria.
· Extended-spectrum penicillins are piperacillin and ticarcillin.
Penicillins side effects
Penicillins are among the safest and least toxic drugs. The most common
side effect of penicillin is Diarrhoea. Nausea, Vomiting, and stomach upset are
also  common.  In  rare  cases  penicillins  can  cause  immediate  or  delayed  allergic
reactions which manifest as Skin rashes, Fever, Angioedema, and Anaphylactic
shock. Severe hypersensitivity reactions are more common after injections than
after oral formulations.
Neurotoxicity
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Very high doses of penicillins, especially in patients with renal
impairment, may cause convulsions[5].
In pregnancy category penicillins come under class B category.
Cephalosporins
Cephalosporins  have  a  mechanism  of  action  identical  to  that  of  the
penicillins. However, the basic chemical structure of the penicillins and
cephalosporins differs in other respects, resulting in different spectrum of
antibacterial activity. Like the penicillins, cephalosporins have a beta-lactam ring
structure  that  interferes  with  synthesis  of  the  bacterial  cell  wall  and  so  is
bactericidal. Cephalosporins are derived from cephalosporin C which is produced
from Cephalosporium acremonium.
Cephalosporins are used to treat pneumonia, tonsillitis, bronchitis, otitis
media, various types of skin infections, gonorrhoea, urinary tract infections
Cephalosporin antibiotics are also commonly used for surgical prophylaxis.
Cephalexin can also be used to treat bone infections.
Cephalosporins are among the most diverse classes of antibiotics, they are
grouped into "generations" by their antimicrobial properties. Each newer
generation has a broader spectrum of activity than the one before.
· The first generation cephalosporins have quite similar spectrums of
activity. They have excellent coverage against most gram-positive
pathogens but contribute to poor coverage against most gram negative
pathogens. The first generation includes:
· cephalothin
· cefazolin
· cephapirin
· cephradine
· cephalexin
· cefadroxil
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· The second generation cephalosporins have expanded gram negative
spectrum in addition to the gram positive spectrum of the first generation
cephalosporins. Cefoxitin and cefotetan have good activity
against Bacteroides fragilis.  Enough  variation  exists  between  the  second
generation cephalosporins in regard to their spectrums of activity against
most species of gram negative bacteria, that susceptibility testing is
generally required to determine sensitivity. The second generation
includes:
· cefaclor
· cefamandole
· cefonicid
· ceforanide
· cefuroxime
· The third generation cephalosporins have much expanded gram negative
activity. However, some members of this group have decreased activity
against gram-positive organisms. They have the advantage of convenient
administration, but they are expensive. The third generation includes:
· cefcapene
· cefdaloxime
· cefditoren
· cefetamet
· cefixime
· cefmenoxime
· cefodizime
· cefoperazone
· cefotaxime
· cefpimizole
· cefpodoxime
· ceftibuten
· ceftriaxone
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· The fourth generation cephalosporins are extended-spectrum agents with
similar activity against gram-positive organisms as first-generation
cephalosporins. They also have a greater resistance to beta-lactamases than
the third generation cephalosporins. Many fourth generation
cephalosporins can cross blood brain barrier and are effective in
meningitis. The fourth generation includes:
· cefclidine
· cefepime
· cefluprenam
· cefozopran
· cefpirome
· cefquinome
Cephalosporins side effects
Cephalosporins are remarkably safe class of antibiotics and usually cause
few adverse effects. Common side effects include: diarrhoea, nausea, mild
stomach cramps or upset. Approximately 5–10% of patients with allergic
hypersensitivity to penicillins will also have cross-reactivity with cephalosporins.
Thus, cephalosporin antibiotics are contraindicated in people with a history of
allergic reactions (urticaria, anaphylaxis, interstitial nephritis, etc) to penicillins or
cephalosporins.
Hematologic toxicity
Thrombocytopenia, neutropenia, abnormalities of platelet function and
coagulation have been reported with certain cephalosporins [6]
Cephalosporin antibiotics are classed under Pregnancy category B.
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Fluoroquinolones (Synthetic Antibiotic)
Fluoroquinolones (fluoridated quinolones) are the newest class of
antibiotics. Their generic name often contains the root "floxacin". They are
synthetic antibiotics, and are not derived from bacteria. Fluoroquinolones belong
to the family of antibiotics called Quinolones.  The older quinolones are not well
absorbed and are used to treat mostly urinary tract infections. The newer
fluoroquinolones are broad-spectrum bacteriocidal drugs that are chemically
unrelated to the penicillins or the cephalosporins. Because of their excellent
absorption fluoroquinolones can be administered not only intravenously but orally
as well.
Fluoroquinolones are used to treat urinary tract infections, skin infections,
and respiratory infections (such as sinusitis, pneumonia, bronchitis).
Fluoroquinolones are bacteriocidal and kill bacteria by interfering with their
ability to make DNA. This activity makes it difficult for bacteria to multiply.
Fluoroquinolones comprises of :
· ciprofloxacin
· levofloxacin
· lomefloxacin
· norfloxacin
· sparfloxacin
· clinafloxacin
· gatifloxacin
· ofloxacin
· trovafloxacin
Fluoroquinolones side effects
Fluoroquinolones are well tolerated and relatively safe. The most common
side effects include nausea, vomiting, diarrhoea, abdominal pain. More serious but
less common side effects are central nervous system abnormalities (headache,
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confusion and dizziness), phototoxicity (more common with lomefloxacin and
sparfloxacin), QT interval prolongation[7], Tendinopathy and tendon rupture[8],
and Convulsions[9].
Fluoroquinolones are generally not recommended for pregnant women and
children.
Tetracyclines
Tetracyclines got their name because they share a chemical structure that
has four rings. They are derived from a species of Streptomyces bacteria.
Tetracycline antibiotics are broad-spectrum bacteriostatic agents and work
by inhibiting the bacterial protein synthesis. Tetracyclines may be effective
against a wide variety of micro-organisms, including rickettsia and amoebic
parasites.
Tetracyclines are used in the treatment of infections of the respiratory
tract, sinuses, middle ear, urinary tract, skin, intestines. Tetracyclines also are used
to treat Gonorrhoea, Rocky Mountain spotted fever, Lyme’s disease, typhus. Their
most common current use is in the treatment of moderately severe acne and
rosacea.
Tetracycline antibiotics are:
· Tetracycline
· Doxycycline
· Minocycline
· Oxytetracycline
Tetracyclines side effects
Common side effects associated with tetracyclines include cramps or
burning of the stomach, diarrhea, nausea, vomiting, esophageal ulceration, sore
mouth or tongue. Tetracyclines can cause skin photosensitivity, which increases
the  risk  of  sunburn  under  exposure  to  UV light.  Rarely,  tetracyclines  may cause
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allergic reactions. Very rarely severe headache and vision problems may be signs
of dangerous secondary intracranial hypertension.
Tetracycline antibiotics should not be used in children under the age of 8,
and specifically during periods of tooth development. Tetracyclines are classed
under  pregnancy  category  D.  Tetracyclines  may  cause  the  gray  to  yellow
discoloration of actively forming teeth and deposition in growing bones.
Macrolides
The macrolide antibiotics are derived from Streptomyces bacteria, and got
their name because they all have a macrocyclic lactone chemical structure.
The macrolides are bacteriostatic, binding with bacterial ribosomes to
inhibit protein synthesis. Erythromycin, the prototype of this class, has a spectrum
and use similar to penicillin. Newer members of the group, Azithromycin and
Clarithyromycin, are particularly useful for their high level of lung penetration.
Macrolide antibiotics are used to treat respiratory tract infections (such as
pharyngitis, sinusitis, and bronchitis), genital, gastrointestinal tract, and skin
infections.
Macrolide antibiotics are:
· Erythromycin
· Clarithromycin
· Azithromycin
· Dirithromycin
· Roxithromycin
· Troleandomycin
Macrolides side effects
Side effects associated with macrolides include nausea, vomiting, and
diarrhoea; infrequently, there may be temporary auditory impairment.
Azithromycin has been rarely associated with allergic reactions, including
angioedema, anaphylaxis, and dermatologic reactions. Oral erythromycin may be
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highly irritating to the stomach and when given by injection may cause severe
phlebitis. Macrolide antibiotics should be used with caution in patients with liver
dysfunction.
Pregnancy category B: Azithromycin, erythromycin.
Pregnancy category C: Clarithromycin, dirithromycin, troleandomycin.
Aminoglycosides
Aminoglycosides are derived from various species of Streptomyces.The
aminoglycosides are bactericidal and work by stopping bacteria from making
proteins.
Aminoglycoside antibiotics are used to treat infections caused by gram-
negative bacteria. Aminoglycosides may be used along with penicillins or
cephalosporins to give a two-prolonged attack on the bacteria. Aminoglycosides
work quite well, but bacteria can become resistant to them. Since aminoglycosides
are broken down easily in the stomach, they can't be given by mouth and must be
injected. Generally, Aminoglycosides are given for short time periods.
Aminoglycoside group includes:
· amikacin
· gentamicin
· kanamycin
· neomycin
· streptomycin
· tobramycin
Aminoglycosides side effects
The  major  irreversible  toxicity  of  aminoglycosides  is
ototoxicity[10] (damage  to  the  ear  and  hearing).  Among  them,  streptomycin  and
gentamicin are primarily vestibulotoxic, whereas amikacin, neomycin,
dihydrosterptomycin, and kanamicin are primarily cochleotoxic.
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Another significant concern with aminoglycoside antibiotics is
nephrotoxicity[11] (kidney damage). Renal damage is related to the accumulation
of high concentrations of aminoglycoside antibiotic in the renal cortex.
Aminoglycosides are classed under Pregnancy Category D
Drug   Utilization   Evaluation
Drug Utilization Evaluation (DUE), is defined as an authorized, structured,
ongoing review of healthcare provider prescribing, pharmacist dispensing, and
patient use of medication. Drug utilization evaluations involve a comprehensive
review of patient’s prescription and medication data before, during, and after
dispensing to ensure appropriate medication decision making and positive patient
outcomes.[5]
Drug therapy is considered to be major component of patient management
in healthcare settings, including primary healthcare. Although the benefit patients
gains from pharmacological interventions are valuable, the risks of drugs and
consequences of inappropriate use cannot be overlooked.[3] The introduction of
potent drugs with an increased incidence of adverse drug reactions,  the high cost
of medication, and a focus on drug use outcomes and the clinical misuse of drugs
may result in preventable patient morbidity and mortality, costly remedial care,
additional cost for diagnosis and management of iatrogenic disease and
unnecessary wastage of health resources. Inadequate knowledge of treatment
regimens, lack of diagnostic competence have contributed to incorrect drug
choices, incorrect dose, adverse drug reactions, drug interactions, and use of more
expensive drugs when less expensive drugs would be equally or more effective. In
recognition  to  this  problem,  DUE  (Drug  Utilization  Evaluation)  has  been
recommended as a method for identifying inappropriate or unnecessary drug use
that monitor, evaluate and promote rational drug therapy. Several factors like
irrational drug use, polypharmacy, incorrect drug choices, incorrect dose, drug
interactions, have contributed to increased morbidity, mortality and health care
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expenses or use of drugs devoid of proven efficacy.[3] The misuse or inappropriate
use of antibiotics leads to increase in healthcare expenses, development of drug
resistance and serious adverse drug reactions.
Drug utilization evaluation studies plays important role in identifying the
prescription pattern among the patients which helps in provide useful information
for improvement of the appropriate and effective use of antibiotics and also
developing the proper protocols for the use of antibiotic in hospitals.
Prescription pattern monitoring studies (PPMS) are a tool for assessing the
prescribing, dispensing and distribution of medicines. Prescription pattern
monitoring studies (PPMS) are drug utilization studies with the main focus on
prescribing, dispensing and administering of drugs. They promote appropriate use
of monitored drugs and reduction of abuse or misuse of monitored drugs. Drug
Utilization Evaluation (DUE) studies are designed to assess drug usage
appropriateness. Drug utilization studies have the potential to make objective
evaluation and analysis of health professionals work and provide them with
feedback to stimulate thinking about their practice and looking for ways to
improve their own performance. To improve the overall drug use, especially in
developing countries, international agencies like the (WHO) World health
organization and International network for the rational use of drugs (INRUD)
have applied themselves to evolve standard drug use indicators. An audit of
antibiotic prescribing patterns is an important indicator of the quality and standard
of clinical practice. A systematic review of prescription pattern monitoring studies
and their effectiveness in promoting rational use of medicines need to be carried
out. The main aim of PPMS is to facilitate rational use of medicines (RUM); and
avoid over prescription of antibiotics or misuse of antibiotics, as it may lead to
antibiotic drug resistances.[12]
Drug utilization studies are powerful tools to ascertain the role of drugs in
the society. They provide a sound socio-medical and health economic basis for
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health care decision making. To achieve this, it is very important to determine the
drug  use  pattern  and  to  monitor  the  drug  use  profiles,  over  time,  by  using  the
Anatomic Therapeutic Chemical Classification (ATC) /defined daily dosage
(DDD) system to serve as a tool for drug utilization in order to improve the
quality of drug use. The WHO specifies drug use indicators for adoptions in the
drug utilization studies.[5]
Drug utilization evaluation aims to assess whether drug therapy is rational
or not. To reach this goal, methods for auditing drug therapy towards rationality
are necessary. Drug utilization evaluation can be divided into descriptive and
analytical studies. The emphasis of the former has been to describe patterns of
drug utilization and to identify problems deserving more detailed studies.
Analytical studies try to link data on drug utilization to figures on morbidity,
outcome of treatment, and quality of care, with the ultimate goal to assess whether
drug therapy is rational or not.
A plethora of drug utilization studies focused on assessing patterns of drug
prescribing  as  a  mean  of  pin-  pointing  areas  for  improvement  with  the  aim  to
rationalize drug use. The health threats that can be caused by improper prescribing
cannot be overlooked. Improper prescribing can cause toxicity for patients and
will be a waste of money and time. It can also cause therapeutic failure that results
in progress of disease conditions and worsening of the patient health condition.
The improper prescribing and excessive use of antibiotics can lead to loss of the
effectiveness of currently used antibiotics. The World Health Organization
(WHO) has repeatedly emphasized the importance of drug utilization studies and
developed indicators examine trends of prescribing and the health facilities. Once
irrational  drug  use  in  its  various  forms  is  determined,  feasible  means  of
intervention are tried with the hope to improve drug use. [6]
Antibiotic resistance was recognized by the World Health Organization as
a serious phenomenon which has emerged due to the pervasive prescription of
antibiotics in practice.
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The development of bacterial resistance to antibiotics has become a major
problem throughout the world. Resistant organisms may emerge as a result of
many factors, including widespread usage, while their spread is mainly caused by
factors in the health care setting, including the health care providers’ behaviour.
The broadest-spectrum antibiotics, such as fourth-generation cephalosporins,
piperacillin-tazobactam and Carbapenems, play an important role in the empiric
therapy of serious nosocomial infections. These antimicrobials are also among the
most expensive.[4] Concern about escalating rates of multi-drug-resistant
organisms and spiralling expenditure on broad-spectrum antimicrobials has
induced most hospitals to implement a range of measures. These include
supervision of their use by infectious disease consultants and/or clinical
pharmacists, provision of continuing education regarding appropriate
antimicrobial drug use, and implementation of automatic stop orders. However,
there is evidence that, in order to be effective, a multidisciplinary approach is
warranted, with application of a range of measures, some of which should be
individualized according to the hospital’s circumstances and means.  Thus one of
the methods increasingly used in this era of cost constraints and quality assurance
is drug utilization evaluation (DUE). This tool was adapted by pharmacists to
assess appropriateness of usage of various medications.[4]The purpose of a DUE is
generally to detect possible problems with, and improve, drug use. DUEs have
traditionally focused on drugs with frequent side-effects, high price tags or
complicated dosing regimens. Very few DUEs have addressed broadest-spectrum
antibiotics, and none has included all three last-line agents.
Excessive prescription of antibiotics not only increases the burden of
antibiotic resistance but also exposes patients to the side effects of these drugs and
increases the treatment costs. Research and evaluation of antibiotic utilization and
antibiotics cost plays an important role in identifying the extent, quality, necessity,
and outcome of antibiotic use. Moreover, calculating the cost of antibiotics
prescribed. [7]
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According  to  WHO the  rational  use  of  drugs  is  the  use  of  the  right  drug,
right dosage at the right cost. "Rational use of drugs requires that patients receive
medications appropriate to their clinical needs, in doses that meet their own
individual requirements for an adequate period of time, at the lowest cost to them
and their community."
Antibiotic drug resistance can be intrinsic or acquired, develops due to
irrational use of antibiotics. Developing new antibiotics is not a solution for this. It
is the responsibility of the healthcare team to develop a good prescribing pattern
which will help in reducing the intensity of the problem. And most of the
alternatives, i.e. second and third line agents are becoming ineffective in clinical
practice. [8]
Microbial resistance to antibiotics is a matter of great importance if
sensitive strains are supplanted by resistant ones, then a valuable drug may
become useless. Based on the mechanism, resistance can be classified as:
Naturally acquired resistance, acquired drug resistance, tolerance (adaptation),
“single step” chromosomal mutation and transmissible drug resistance.[13]
Surveillance of bacterial resistance is a key element in understanding the
size  of  the  problem.  The  large  number  of  existing  networks  of  resistance
surveillance needs to be coordinated, and the results made available. To help
doctors choose appropriate antibiotics and to detect local epidemics of resistant
bacteria surveillance at local level is necessary by resistance can be minimized.
There are two-ways of fighting the development and spread of resistance. The first
is to reduce the use of antimicrobial agents. About 85-90% of antibacterial drugs
are  used  in  the  community,  and  up  to  80% of  these  are  used  to  treat  respiratory
tract infections. Sales of antibiotics over the counter should be stopped. The
second major way to tackle resistance is by improving hygiene measures to
prevent the spread of transmissible diseases. In hospitals, effective prevention of
cross infection and the development of strict antibiotic policies should be in the
hands of experts. Each hospital thus needs an infection control team with
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infectious disease specialties, clinical microbiologists, and infection control
nurses, and sufficient resources are a mandate to run the program. Antibiotics are
prescribed unnecessarily and empirically for complaints where no antibiotic is
required or where culture and sensitivity results could be safely awaited. Thus,
continuous monitoring of the pattern of bacterial resistance serves as empiric
guide for therapy. Empirical antibiotic therapy should be given when bacterial
infection is suspected and poses a sufficient health risk to demand immediate
treatment. Eg: Pyrexia of unknown origin, Meningitis, Tuberculosis. Problems
with empirical therapy are: Prescribing antibiotics to patients who do not have a
bacterial infection, inappropriate antimicrobials may be selected. Hence, an urgent
need exists for less frequent use and more appropriate selection of antimicrobial
drugs. Before starting an antibiotic for a patient, the clinician must consider
whether  the  antibiotic  is  suitable.  The  importance  of  determining  the  type  and
sensitivity  of  the  causative  organism is  obvious.  The  key  action  by  the  clinician
should be the provision of a specimen for accurate identification of the offending
pathogen by means of culture and sensitivity method .[13]
The study of prescribing patterns seeks to monitor, evaluate and suggest
modifications in practitioners’ prescribing habits so as to make medical care
rational and cost effective. Information about antibiotic use patterns is necessary
for a constructive approach to problems that arise from the multiple antibiotics
available. [9]
WHO deﬁnes an adverse event as any untoward medical effect that occurs
during drug therapy but not necessarily with a causal relationship with the
treatment. Therefore, from the occurrence’s perspective, Adverse Drug Reactions
(ADR’s) and Medication Error (ME) can be considered adverse drug events.
Adverse drug reactions (ADRs)  deﬁned by the World Health Organization
(WHO) as “any noxious, unintended effect to the use of a drug, which occurs at
doses usually used in humans for prophylaxis, diagnosis or therapy or for
modifying a physiological action”. This deﬁnition assumes the correct use of a
drug and reﬂects the intrinsic risk to its use. Therefore, these are non- preventable
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events. In contrast, medication errors (MEs) are deﬁned as “any preventable event
that may cause patient harm or lead to inappropriate medication use while the
medication is in the control of the health care professional, patient, or consumer.10
Such events may be related to professional practice, procedures, and systems,
including prescribing, order communication, product labeling, packaging,
nomenclature, compounding, dispensing, distribution, administration, education,
monitoring, and use. Adverse drug events in hospitalized patients are an emerging
condition associated to signiﬁcantly increased hospital stay, costs, and morbidity.
Adverse drug events are a public health concern because of its high occurrence
incurring in additional costs to health services.[11]
The cost of drug therapy is increasing dramatically, especially as new
products, derived from various methods, are being introduced. Cost is one among
the various factors to be taken into account in antibiotic prescribing. The
unnecessary  use  of  antibiotics  has  imposed  a  huge  burden  on  the  patients.  With
this  basis  the  study  was  planned  to  assess  the  drug  utilization  evaluation  of
antibiotics in the hospital.
            Evaluation of prescribing pattern will also help in minimizing adverse drug
reactions and it shall also aid in providing cost effective medical care. Therefore,
this study would help us to monitor the prescribing pattern and cost of antibiotics
so that these can be used judiciously.
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LITERATURE REVIEW
1. R Selvaraj et al (2015)[1] conducted a study to assess rational use of
antimicrobials in the medicine outpatient department of a teaching
hospital. A total of 650 prescriptions were collected from the medicine
OPD. Prescriptions containing antimicrobial were grouped using the
anatomical therapeutic chemical (ATC) codes. They concluded that higher
frequency of irrational antimicrobial prescriptions suggests that
antimicrobial restriction policies and a multidisciplinary effort to reduce
usage are urgently required.
2. Mohanraj Rathinavelu et al (2015)[2]conducted a study to evaluate the
pattern of drug utilization in inpatients of general medicine department.
The  data  for  study  was  obtained  from 80  inpatients  prescriptions  and  the
DDD/100 bed days were calculated. The study indicate that there
improvement in prescribing pattern of antibiotics is possible by adhering to
standard guidelines of treatment and restriction policies to promote
rational drug use.
3. Admane PD et al (2015)[3]carried  out  a  study  to  assess  the  use  of
antimicrobials in tertiary care hospital. A prospective cross sectional study
was conducted in outpatient department over a period of 8 months and
total 1942 prescriptions were collected. The study results analysed that the
rational use of antimicrobial agents is needed to control antibacterial
resistance, side effects and reduced cost of the treatment.
4. Greeshma Hanna Varghese et al (2015)[4]carried out a prospective
observational study over a period of  months and screened 1139
prescription to  assess the patterns of drug utilization evaluation by WHO
prescribing indicators among special population in a tertiary care
government teaching hospital retrospectively and prospectively.  The study
concluded that it is necessary  to avoid  over prescription, follow
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guidelines while prescribing drugs generic name, reduce the use of
antibiotics after susceptibility testing , to minimize the use of injections
and  to  confine  to  the  National  essential  drug  list  are  necessary  to  further
improve rational use of drugs.
5. Maheshwari P et al (2015)[5]studied on the patient’s awareness on the
rational use of antibiotics and its resistance by developing a questionnaire.
The study revealed that there was a very high consumption of antibiotics
mainly cephalosporin’s. Dispensing of antibiotics is very high in
community pharmacy despite of federal regulations. They proposed health
education programmes should be given to the patients regarding
antibiotics.
6. Venu Gopal D  et al (2014)[6] conducted a prospective observational study
in a tertiary care teaching hospital for six months in general medicine and
screened 555 antibiotic prescription. The study concluded that the clinical
pharmacists and Clinicians need to play vital role in minimizing the
antibiotic problems by conducting continual awareness programs
regarding up-to-date prescribing guidelines in the hospital and also
minimizing the antibiotic resistance. The active participation of clinical
Pharmacists in the clinical ward rounds and documentation of Pharmacist
observation on prescription in patient folder is highly recommended for
safety and drug monitoring.
7. M. Shamna et al (2014)[7]]carried out a prospective study in all
departments for a period of one year to detect and analyse adverse drug
reaction of antibiotics in inpatients of a tertiary care hospital. The study
concluded that adverse drug reaction to antibiotics is getting common and
it resulted in increased health care cost and length of hospital stay.
Therefore  study suggest that health system should promote the
spontaneous reporting of adverse drug reaction to antibiotics , proper
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documentation and periodic reporting to regional pharmacovigilance
centres to ensure drug safety.
8. Mujtaba Hussain et al (2014)[8]  conducted a    prospective, observational
study of antibiotic prescribing patterns at admission in an open, mixed
medical surgical, adult, ICU in a tertiary care hospital including 110
patients to  determine the group of antibiotics that are prescribed for
various illnesses, average number used and the cost of antibiotics per
prescription. The study concluded that there is a need for guidelines and
protocol for treatment at all levels of health care especially with respect to
antibiotics.
9. Meher B. R. et  al  (2014)[9] conducted a prospective study in 200 patients
in general medicine department to  obtain information about demographic
profiles of patients, prevalence of infectious diseases and prescribing
pattern of antibiotics of a tertiary care teaching hospital. The study
concluded that a strict protocol for prescribers is required   to promote
rational use of antibiotics which would not only prevent antibiotic
resistance but also reduce the treatment expenditure in hospitals.
10. Shalini et al (2011)[10] studied on antibiotic sensitivity pattern in urinary
tract infection at a hospital. The most common samples isolated were
Escherichia coli, Klebsiella, Pseudomonas, and Staphylococcus
aureus.E.coli showed high sensitivity to Amikacin and Nitrofurantoin.
E.coli isolates were also sensitive to Minocycline, showing a good utility
of this drug for the treatment for patients with urinary tract infections.
11. Mayadah Shehadeh et al (2011)[11] studied on the knowledge, attitudes
and behaviour regarding antibiotics use and misuse among adults in the
community  of  Jordan.  The  study  showed  that  knowledge  of  when
antibiotics should be used, the efficacy of antibiotics as well as the risk of
antibiotic resistance is inadequate in study population. To prevent the
inappropriate antibiotics consumption the health authorities had to
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implement their regulations to prohibit the selling of Prescription Only
Medicine (POM) without prescription.
12. Estela Louro et al (2007)[12]studied on adverse events to antibiotics in
inpatients of a university hospital. The aim of the study was to evaluate the
occurrence of adverse events to antibiotics in inpatients of a hospital. The
study results indicate that an inadequate knowledge on antibiotics or lack
of information about the patient at the time of prescription were the major
factors involved in the occurrence of adverse event
13. M.V. Srishyla,  et al (2007) [13] conducted a study including 556 in
patients to assess prescription on the basis of type of use, speciality, site
of infection, route of administration and the antimicrobial agent used. The
study showed that 56% of in-patients were prescribed antimicrobial agents
and 44% of them received a combination of antimicrobials and concluded
that there is need of  review of antimicrobial prescribing practices.
14. David L Peterson (2005)[14] studied on the role of antimicrobials
management programs in optimizing antibiotic prescribing within hospital.
The study was mainly done on patients receiving a broad spectrum
antimicrobial agent, fluroqunolones, vancomycin and cephalosporin for a
period of 48 hours. It was found that the spectrum was too broad on the
basis  of  result  of  microbiological  testing  and  the  use  of  vancomycin  was
unnecessary in certain cases.
15. Ravi Pathiyil Shankar et al (2003)[15]carried out a over a period of
3 month including 203 patients study to collect demographic information,
antibiotic prescribing patterns, and common organism isolated including
antibiotic sensitivity patterns. The study concluded that antibiotic
resistance is getting common, therefore formulation of policy for hospital
antibiotic use and should organise educational programs especially for
junior doctors.
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SCOPE OF THE STUDY
Antibiotics are considered as the greatest discovery of the twentieth
century. Successful use of antibiotics has brought a revolutionary change in
management of infectious diseases but it also resulted over use and misuse of
antibiotics. Antibiotics today are commonly prescribed drugs in a hospital set up.
The emergence of antibiotic resistant bacteria is a major problem throughout the
world and a rational use of antibiotics is therefore very important. Irrational use of
antibiotics can cause increase adverse drug reaction, lead to antibiotic resistance
and increase the treatment cost. Assessment of pattern of antibiotics utilization is
significant in the context of its increase use and its overall impact on the health
care system.
Almost one third of the people receive one or the other antibiotics during
the course of hospital stay. However antibiotics have become one of the misused
therapeutic agents available to the medical profession. One drawback of such
large scale use of antibiotic is the emergence of antibiotic resistant pathogens.
Antibiotic resistance is the ability of bacteria to repel or withstand the effects of an
antibiotic. The increased resistance is a result of many factors, but the foremost
cause is the overall volume of antibiotic consumption. Antimicrobial resistance is
not only increasing the healthcare costs, but also the severity and death rates from
certain infections that could have been avoided by prudent and rational use of the
existing and newer antimicrobial agents.
More than 70% of the bacteria that cause hospital acquired infection are
resistant  to  at  least  one  of  the  drug  most  commonly  used  to  treat  them.  Some
bacteria are resistant to all approved antibiotics and must be treated with
experimental and potentially toxic drugs. Persons infected with drug resistant
bacteria  are  more  likely  to  have  longer  hospital  stays  and  require  treatment  with
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second or third choice drugs that may be less effective, more toxic and more
expensive. Antibiotic resistance is driving up health care cost, increasing the
severity of disease and increasing the death rate from certain diseases. The terms
methicillin resistant Staphylococcus aureus, Vancomycin resistant enteroccoci
and multidrug resistant tuberculosis are heard all too often in today’s world.
Prudent and rational use of antibiotics is possible by forming local, national, and
global wide antibiogram. The antibiotic sensitivity pattern can help in identifying
the pathogen responsible for the infection thereby antibiotic susceptible against
that particular pathogen can be administered to the patient. The sensitivity pattern
has helped in declining the severity and death rate from infection by the prudent
and the rational use of antibiotics.
The present study aimed to identify prescribing pattern of antibiotics, ADR
involved, antibiotic sensitivity and cost comparison. Drug utilization research
facilitates the rational use of drugs and suggests a way to improve prescribing
habits.
Objectives of the Study
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OBJECTIVES OF THE STUDY
Ø To study the prescribing pattern of antibiotics.
Ø To study the pattern of antibiotic sensitivity
Ø To identify the adverse effects of antibiotics.
Ø To assess the cost comparison of antibiotics.
Plan of the Study
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PLAN OF THE STUDY
The entire study was planned to be carried out for a period of 10 months
from November 2015- August 2016. The proposed study was designed in four
phases to achieve the objectives.
PHASE I
v Literature survey
v Preparation of Protocol
v Obtaining consent from the hospital authorities
PHASE II
v Preparation of patient consent form
v Designing of structured data entry format
v Data collection
v Documentation of collected data using the data entry format
PHASE III
v Analysis of all the collected data
v Graphical representation of the data
v Interpretation of the data
v Statistical analysis of all the collected data
PHASE IV
Ø Preparation of the project report and submission to the study department
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METHODOLOGY
STUDY SITE
The proposed work entitled “Drug utilisation and evaluation of antibiotics
at a tertiary care hospital” was carried out in a 750 bedded multi-speciality
institution, one of largest hospitals in Coimbatore. The various specialities include
General Medicine, Anaesthesiology, Orthopaedics, Radiology, Nephrology,
Pulmonology and critical care, cardiology, cardiothoracic Surgery, Microbiology,
Pathology, Haematology, Laparoscopic surgery, ENT, Dental and Maxillofacial
Surgery, Neurology, Ophalmology, Physical Medicine and rehabilitation
Diabetology, Surgical Gastro Enterology, Oncology. The hospital is also equipped
with the modern diagnostic facilities like CT scan, MRI scan, ultrasound
Sonography, Digital Subtraction Angiography (DSA), ECG, Treadmill, Colour
Doppler etc. The hospital also has twelve hi-tech operation theatres, Intensive care
unit. Intensive cardiac unit, Intensive pulmonary care unit, Catheterization,
Balloon  Valvoplasty, Coronary stenting, Kidney Transplantation units with
Haemodialysis machines and an assisted Reproductive Technology Centre.
DEPARTMENT SELECTED FOR STUDY IN THE HOSPITAL
The department selected for the study was general medicine department.
The reason for selection of this department was that it had plenty of patients with
different co morbid conditions being dealt with different class of antibiotics which
is the actual requirement for the study. Pharmacy Practice Department provides
services to the department and a good cooperation from the medical team added
up to the reason for selecting this department for conducting the study.
CONSENT FROM HOSPITAL AUTHORITIES
The protocol of the study includes the scope of the study, objectives,
methodology and outcome. The protocol was presented to the members of ethical
committee for approval and the authorisation from the dean to carry out the study
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was procured through his letter [SRH/EC.5-9/2016-17 Dated February 2016]
and  the  same  is  attached  for  the  reference  in  the [Annexure 1].  The  study  was
conducted with the expert guidance of senior and junior physicians of the study
department.  The  author  was  allowed  to  utilize  the  hospital  facilities  to  make  a
follow  up  of  the  cases,  in  the  selected  department.  The  entire  health  care
professionals were well informed through Dean’s official circular.
LITERATURE SURVEY
Literature survey was carried out regarding the different aspects that
should be considered while doing a study based on drug utilization of antibiotics.
These include various drug utilization studies, prescribing patterns, identifying the
adverse effects, sensitivity patterns, developing questionnaires and cost
comparison studies. The literature supporting the study was gathered from various
journals.
Ø Study Site: General Medicine Department
Ø Study Design: Prospective observational study
Ø Study Duration: 10 months ( November – August)
Ø Sample Size: 150 patients
PATIENT SELECTION
· Inclusion Criteria: Patients of all age of either sex getting admitted in the
study  site  during  the  study  period,  who  have  been  prescribed  with
antibiotics and are willing to participate, are included in the study.
· Exclusion Criteria: Patients in which the antibiotics are not prescribed
and those who are not willing to participate in the study are excluded.
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PATIENT INFORMATION FORM
A patient information form was prepared to inform the patient or the care
givers about the purpose and necessity of the study. The patients were assured that
the confidentiality will be strictly maintained. The model of the information form
is given in [Annexure 2] for the reference.
PATIENT CONSENT FORM
A patient consent form has been prepared and written consent was
obtained from the caregivers. The format contains details like address, date, place,
provision for signature of the patient or caregivers, investigator and supervisor.
The same is given in the [Annexure No. 2] for reference.
DATA ENTRY FORMAT
A specially designed data entry format was used to enter all patient’s
details like patient name, age, sex, date of admission, date of discharge, reason for
admission, past medical history, medication history, social history, vital signs like
temperature, BP, and pulse.
Provision is given in the format to enter laboratory investigations like
Blood sugar level(FBS,PPS,RBS),Blood counts (Hb, TLC,ESR, Platelet count,
Clotting time, Bleeding time, Liver function test, Renal function test, Electrolytes,
urine examination, Diagnosis, Co-morbidities associated, Drugs prescribed, Drug
interactions, Adverse effects and any interventions.
METHOD
The data was collected during regular ward round participation in the
department of General Medicine. Standard data entry format was used to enter all
the patient details collected during ward rounds. The prescriptions were
individually screened to assess the prescribing pattern of antibiotics. The DDD is
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the assumed average maintenance dose per day for a drug used for its main
indication in adults. DDD/100 bed-days (Defined Daily Dose) of 10 most
commonly prescribed antibiotic was calculated. DDD/100 bed- days provides at
estimate of consumption of drugs in general medicine department. And also ATC
code of the antibiotics were recorded.
The sensitivity patterns of the antibiotics were evaluated with the help of a
suitable antibiogram provided from the microbiological laboratory.
The adverse effects of the antibiotics were monitored during drug
administration and the information on any adverse effect of the drug experienced
by the patient was gathered during the ward rounds and reported
The cost comparison of the antibiotics was assessed by analysing the
prescribed  brand  of  antibiotic  in  the  hospital  with  the  other  brand  of  the  same
antibiotic which is available in the market. Cost of prescribed antibiotics and
alternate antibiotics of same class were statistically analysed.
STATISTICAL ANALYSIS
In this study used SPSS (Statistical Package for the Social Sciences) was
used to compare the cost of prescribed antibiotics to alternate antibiotics of same
class.  Other  statistical  tools  like  ANOVA and  Chi  Square  were  also  used  in  the
study
REPORT SUBMISSION
The reports on the study were prepared and the same was submitted to the
study department.
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RESULTS
                                 TABLE No. 1: GENDER CATEGORIZATION
Sl. No. Sex No.  of cases (n=150) Percentage (%)
1. Male 90 60
2. Female 60 40
FIGURE No. 1: GENDERWISE CATEGORIZATION
The study result shows that 60% of the patients were male and 40% were
female.
60%
40%
Male Female
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TABLE No. 2: AGEWISE DISTRIBUTION
Sl.No. Age No. of patients prescribed (%)(n=150)
Percentage
(%)
1. < 20 2 1.3
2. 20 – 40 33 22
3. 41- 60 55 36.6
4. 61-80 57 38
5. > 80 3 2
FIGURE No. 2: AGEWISE DISTRIBUTION
Agewise distribution  of  the  patients  were  analysed  and  it  was  found  that
1.3% of the prescriptions were in the age group of less than 20 years, followed by
22% in the age group of 20-40 years, 36.6% in the age group of 41-60 years, 38%
in the age group of 61-80 years and 2% in the age group above 80 years.
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TABLE No. 3: COMORBID CONDITIONS IN STUDY POPULATION
Disease condition No. Of patients (%), n=150 Percentage (%)
Diabetes 51 34
Renal disorders 24 16
Thyroid disorders 7 4.6
Hypertension 48 32
dyslipidemia 37 24.6
Urinary tract infections 7 4.6
Gastro intestinal disorders 47 31.3
CNS disorders 18 12
Cardiovascular diseases 22 14.6
Others 43 28.6
FIGURE No. 3: COMORBID CONDITIONS
In the study on analysing co morbidities of study population it was noted
that 34% were affected with diabetes followed by 16% with renal disorders, 4.6%
with thyroid disorders, 32% with hypertension, 37% with dyslipidemia,7%with
urinary tract infections, 47%with gastrointestinal disorders, 18%with CNS
disorders and 22% of the patients with cardiovascular diseases.
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            TABLE No. 4: CLASS OF ANTIBIOTICS PRESCRIBED
Sl.No. Antibiotic  class No. of  prescription(n=150) Percentage (%)
1. Cephalosporins 83 55.3
2. Pencillins 70 46.6
3. Nitroimidazole 24 16
4. Fluoroquinolones 26 17.3
5. Macrolide 3 2.0
6.. Lincosamide 3 2.0
7. Carbapenams 12 8.0
8. Aminoglycoside 13 8.6
9. Imidazole 2 1.3
10. Tetracyclins 3 2.0
11. Glycopeptide 1 0.6
12. Oxazolidinone 1 0.6
13. Broad spectrumantibiotic 16 16.0
FIGURE NO. 4:CLASS OF ANTIBIOTICS PRESCRIBED
The study reports that the major class of antibiotics prescribed among
patients were cephalosporins constituting about 55.3% followed by pencillins
(46.6%), Nitroimidazole (16%), Fluoroquinolones (17.3 %), Macrolide (2%)
lincosamide (2%) carbapenams (8%), aminoglycosides. (8.6%), midazole (1.3%),
Tetracyclins (2%), Glycopeptide (0.6 %), Oxazolidinedione (0.6%) and Broad
spectrum antibiotics about 10.6% in patients.
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TABLE No. 5: COMMONLY PRESCRIBED ANTIBIOTICS
P Antibiotics prescribed No. ofprescription(n=150) Percentage(%)
1 Piperacillin/tazobactum 61 40.6
2 Ceftriaxone 37 24.6
3 Metronidazole 12 8
4 Amikacin 10 6.6
5 Cefpodoxime 8 5.3
6 Rifaximin 7 4.6
7 Ofloxacin 6 4
8 Ceftriaxone + tazobactum 4 2.6
9 Cefixime 4 2.6
10 Clarithromycin 3 2
FIGURE No. 5: COMMONLY PRESCRIBED ANTIBIOTICS
The study reports that 40.6% of the prescriptions were prescribed with
piperacillin / tazobactum  24.6% with Ceftrixone,8% with Metronidazole,6.6%
with Amikacin and 5.3% of the prescriptions were prescribed with Cefpodoxime .
TABLE No. 6: NUMBER OF ANTIBIOTICS PRESCRIBED (N=150)
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S.No. No. of antibiotics No. of  patients prescribed  Percentage (%)
1. 1 73 48.6
2. 2 47 31.3
3. 3 20 13.3
4. 4 6 4
5. 5 4 2.6
FIGURE No. 6:  NUMBER OF ANTIBIOTICS PRESCRIBED
During  the  hospital  stay,  most  of  the  patients  were  prescribed  with  only
one antibiotic i.e. 73 patients, 47 patients with 2 antibiotics, 20 patients with
3  antibiotics,  6  patients  with  4  antibiotics   and  only  4  patients  were  prescribed
with 5 antibiotics.
TABLE No. 7: REASON FOR ANTIBIOTIC PRESCRIPTION (N=150)
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Sl.No. Antibiotic   prescribed for No. of patientsprescribed Percentage (%)
1. Prophylaxis 45 30
2. BPI 62 41
3. Non- BPI 43 29
FIGURE No. 7: REASON FOR ANTIBIOTIC PRESCRIPTION
The study shows that 41% of the patients were prescribed with antibiotics
for Bacteriologically Proven Infection (BPI) followed by 29% of patients for Non
Bacteriologically Proven Infection (Non-BPI) and 30% of the patients for
prophylaxis.
TABLE No.  8: THERAPEUTIC OUTCOMES OF ANTIBIOTICS
[PERCENTAG
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FIGURE No. 8: THERAPEUTIC OUTCOMES OF ANTIBIOTICS
The therapeutic outcomes of antibiotics among patient’s reports that
around 49% of the patients were completely cured by the therapy and about 45 %
of  the  patients  showed  controlled  response  on  therapy  and  around  6%  of  the
patients had no improvement.
Sl.No. Therapeuticoutcomes
No. of patients prescribed
(n=150)
Percentage
(%)
1. Cured 73 49
2. Controlled 68 45
3. No improvement 9 6
49%
45%
6%
Cured Controlled No improvement
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Table No. 9: FACTORS AFFECTING THE NUMBER OF ANTIBIOTICS
PRESCRIBED (n=150)
No. of Antibiotics p
valuen 1Antibiotics
2
Antibiotics
> 2
Antibiotics
Gender Male 90 46 23 21 0.248Female 60 29 22 9
Age
< 20 3 1 1 1
0.850
21-40 33 16 9 8
41-60 55 27 17 11
61-80 56 28 18 10
> 80 3 3 0 0
Duration
of stay
< 5 days 43 28 9 6
0.015*5 days 23 11 11 1
> 5 days 84 36 25 23
P<0.05 is considered significant
In the study number of antibiotics prescribed was compared with gender,
age and duration of treatment and it was found that most of patients were
prescribed with one antibiotics. In comparison to gender, 46 males were
prescribed with single antibiotics whereas only 29 females were prescribed with
single antibiotics. When compared to age groups most of patients in age group of
41-60 and 61 -80 were prescribed with single antibiotic during the study. The
study reports that only duration of stay was found to be statistically significant
(p= 0.015).
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FIGURE NO.9: DURATION OF STAY WITH NUMBER OF
ANTIBIOTICS PRESCRIBED
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TABLE No.10: DDD/100 BED- DAYS AND ATC CODE OF ANTIBIOTICS
In the study DDD/100 bed – days of the 10 most common antibiotics was
calculated.  .  In  the  study  the  antibiotic  use  was  found  to  be  0.7461  DDD/  100
beds- days. The study was carried out for a period of 180 days and average
occupancy index was 0.72. The 10 most common antibiotics were classified using
the Anatomical Therapeutic Chemical (ATC) Classification given by WHO
International Working Group for Drug Statistics Methodology. The main purpose
of this classification is for international drug utilization research and for adverse
drug reaction monitoring.
SENSITIVITY PATTERN OF ANTIBIOTICS
Sl.No. Name of Antibiotics DOSE DDD/100bed- days ROA
ATC
code
1 Piperacillin/tazobactum 4.5 gm 0.2269 IV J01CR05
2 Ceftriaxone 1.0gm 0.35 IV J01DD04
3 Metronidazole 500mg 0.026 IV J01XD01
4 Amikacin 500mg 0.0175 IV J01GB06
5 Cefpodoxime 100mg 0.007 Oral J01DD13
6 Rifaximin 400mg 0.0105 Oral A07AA11
7 Ofloxacin 200mg 0.007 IV J01MA01
8 Ceftriaxone +tazobactum 1.0gm 0.0701 IV J01DD54
9 Cefixime 200mg 0.0224 Oral J01DD08
10 Clarithromycin 500mg 0.0087 Oral J01FA09
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TABLE No. 11:   ORGANISMS ISOLATED
Sl.no Organism Number of patients(n=22)
Percentage
(%)
1 Klebsiella Pneumonia 10 45.4
2 E.Coli 5 22.7
3 Enterococcus Faecalis 4 18.1
4 Streptococcus Aureus 3 13.6
FIGURE No. 11: ORGANISMS ISOLATED
The study shows different strains of organisms that were isolated from the
patients culture test .Among the isolated organisms the most common were
Klebsiella pneumoniae 45.4%, followed by E.coli 22.7%, Enterococcus faecalis
18.1% and Strep. aureus 13.6% were reported in the culture samples.
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TABLE No. 12: SPECIMEN SAMPLE USED FOR CULURE SENSITIVITY
Sl.no Specimen used Number of patients (n=22) Percentage (%)
1 Sputum 7 31.8
2 Urine 5 22.7
3 Blood 5 22.7
4 Tracheal culture 3 13.6
5 Pus 1 4.54
FIGURE No. 12 SPECIMEN SAMPLE USED FOR CULURE  SENSITIVITY
The specimen samples  used in the culture sensitivity was Sputum 31.8%,
Urine 22.7%,Blood 22.7%, Tracheal Culture 13.6% and Pus 4.54%.
TABLE NO. 13: SENSITIVITY PATTERN TOWARD VARIOUS
ANTIBIOTICS
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Klebsiella pneumoniae 9  9 7 1 1 3 3  1  1
E.coli 3  3 3 4 - 2 1  1  2
Enterococcus faecalis 1  1 1 3 - 3  3  -
Staphylococcus aureus 2  3 3 - 1 2 -  -  3
FIGURE No. 13: SENSITIVITY PATTERN TOWARD
VARIOUS ANTIBIOTICS
In the study 22 cases were subjected to antibiotic sensitivity studies,
which   revealed that K. pneumonia were higly sensitive to Amikacin and
Imipenem, E. coli were sensitive to piperacillin/ tazobactum, E. faecalis were
sensitive to piperacillin/ tazobactum, Gentamycin and Ofloxacin, S. aureus were
sensitive to  Imipenem, Meropenam and Cefriaxone.
TABLE NO. 14: ADR BASED ON GENDER
Sl
No. Sex No.  of  ADR(n=12) Percentage
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1. Male 9 75
2. female 3 25
FIGURE No. 14: ADR BASED ON GENDER
The study reports revealed that the adverse drug reactions(ADR) are found
to be more prone among males constituting to about 75% of the patients and to
about 25% in female patients.
[PERCENTA
GE]
[PERCENTA
GE]
Male Female
Sl.No. Age No. of ADR(n=12) Percentage (%)
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TABLE No. 15: ADR BASED ON AGE GROUP
FIGURE No. 15: ADR BASED ON AGE GROUP
Adverse drug reactions based on age group showed that  the patients who
were at an age group of 61-80 years were mostly affected to about 41.6%
followed by 41-60 years at 33.3 %  and patients at an age group 20-40 years were
least affected by the adverse reactions to antibiotics which constituted to only
about 25%.
TABLE No. 16: AGE AND GENDER WISE DISTRIBUTION OF ADR
Sl. Age Male Female Total no. of ADR Percentage
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1. < 20 0 0
2. 20 – 40 3 25
3. 41- 60 4 33.3
4. 61-80 5 41.6
5. > 80 0 0
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No. (n=12) (%)
1 < 20 0 0 0 0
2 20 – 40 3 0 3 (16.6%) 16.6
3 41- 60 2 2 4 (33.3%) 33.3
4 61-80 5 0 5 (41.6%) 41.6
5 > 80 0 1 1 (8.3 %) 8.3
FIGURE No. 16: AGE AND GENDER WISE DISTRIBUTION OF ADR
The age and gender wise distribution of ADR showed that 41.6% of male
patients in the age group of 61-80 were more affected , followed by 25% of male
patients in the age group of 20-40 were affected. In the age group of 41-60 both
male and female were equally prone to the reaction to about 16.6%. About 8.3%
of the female patients were affected in the age group of more than 80 years.
TABLE No. 17: CLASS OF ANTIBIOTICS CAUSING ADR
Sl No. Antibiotic  class No. of ADR (n=12) Percentage (%)
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1 Pencillins 5 41.6
2 Cephalosporins 1 8.3
3 Macrolide 2 16.6
4 Fluoroquinolones 1 8.3
5 lincosamide 1 8.3
6 Nitroimidazole 2 16.6
FIGURE No. 17: CLASS OF ANTIBIOTICS CAUSING ADR
The major class of antibiotics causing adverse drug reactions in patients
were found to be Pencillins (41.6%), followed by Cephalosporins (16.6%),
Macrolide (16.6%), Fluoroquinolones (8.3 %), Lincosamide (8.3%) and
Nitroimidazole (16.6%) were being reported in the study.
TABLE No.18:   ANTIBIOTICS CAUSING ADR
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FIGURE No. 18: ANTIBIOTICS CAUSING ADR
The major antibiotics causing adverse drug reactions in patients were
found to be Piperacillin/Tazobactum in 41.6%,followed by Clarithromycin
in16.6% ,Ceftriaxone in 8.3% , Ofloxacin in 8.3 % , Metronidazole  in 16.6%  and
Clindamycin in 8.3% of the patients were being reported in the study.
TABLE No. 19: CAUSALITY ASSESSMENT
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FIGURE No. 19: CAUSALITY ASSESMENT
The adverse drug reactions assessment by WHO causality assessment
scale showed that around probable ADR’s counted for 36.3% and possible ADR’s
counted for 33.3% among the patients.
TABLE No. 20: REACTION OBSEREVED DURING ADR
Sl No. Type of reaction No. of  ADR (n=12) Percentage %
1 Thrombophlebitis 2 16.6
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1 Certain 0 0
2 Possible 4 33.3
3 Probable 8 36.3
4 Unlikely 0 0
5 Unclassifible 0 0
6 Conditional 0 0
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2 Eosinophilia 1 8.3
3 Constipation 1 8.3
4 Itching 2 16.6
5 Haemolytic anaemia 1 8.3
6 Vomiting 1 8.3
7 Giddiness 1 8.3
8 Abdominal pain 1 8.3
9 Haemolytic uremicsyndrome 1 8.3
10 Decreased potassium level 1 8.3
FIGURE No. 20: REACTION OBSERVED DURING ADR
The  reactions seen in patients were Thrombophlebitis in 16.6%,
Eosinophilia in 8.3%, Constipation in 8.3%, Itching in  16.6%, Haemolytic
anaemia in 8.3%, Vomiting in 8.3%, Giddiness in 8.3%, Abdominal pain in 8.3%,
Haemolytic uremic syndrome in 8.3% and Decreased potassium level in 8.3%
patients were being reported.
TABLE No. 21: ADR BASED ON LEVEL OF SEVERITY (N=12)
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Sl.No. Level of severity No. of ADR Percentage (%)
1 Mild 5 41.6
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FIGURE No. 21: ADR BASED ON LEVEL OF SEVERITY
Based on the level of severity, Mild reactions constituted to about 41.6%,
Moderate reactions  to about58.3%  and  no severe reactions were observed or
reported in patients.
                                            TABLE No. 22: OUTCOMES (N=12)
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2 Moderate 7 58.3
3 Severe 0 0
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2. Recovering 0
3. Fully recovered 12
4. Unknown 0
5. Others 0
FIGURE 22: OUTCOMES
In the study all ADR among the patients were fully recovered during the
hospital stay.
TABLE 23: COST COMPARISON OF ANTIBIOTICS (N=150)
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Gender
Male 90 2014.31±2199.70
0.636
1189.49±1320.03
0817
Female 60 1841.77±2152.65 1139.83±1233.23
Age
< 20 3 1941.68±2043.03
0.883
1159.65±819.02
0.980
21-40 33 1872.19±1950.19 1055.33±833.79
41-60 55 2144.59±2481.09 1220.00±1371.73
61-80 56 1843.45±2067.70 1198.11±1458.78
> 80 3 1000.23±970.46 981.66±984.19
Duration
of stay
< 5
days 43 1824.94±2394.95
0.323
1170.29±1503.86
0.6125 days 23 1412.87±1841.76 933.27±1215.11
> 5
days 84 1945.29±2175.39 1234.01±1181.16
Total 150 1945.29±2175.39 <0.001 1169.63±1282.04 < 0.001
In the study cost of antibiotics prescribed and cost of alternate antibiotics
were calculated.  The total cost was Rs.1945.29±2175.39 whereas for alternate
antibiotics Rs. 1169.63±1282.04. In comparison to gender, males had more cost
for antibiotics than females.  Cost of antibiotics was also compared with age and
duration of stay and by comparing mean value of cost and alternate of antibiotics,
latter had less cost than former antibiotics prescribed.
TABLE NO: 24 DRUG INTERACTIONS ( N=150)
Severity No. of Patients Percentage (%)
Major 30 20
Moderate 95 63.3
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Minor 25 14.6
FIGURE NO: 24 DRUG INTERACTIONS
The severity of drug interactions were evaluated and categorized into
major,  moderate  and  minor  type  interactions.  It  was  observed  that  65%  of  the
interactions had moderate severity 20% of the interactions had major severity and
15% come under minor interactions.
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DISCUSSION
The current study on gender categorization had revealed that the overall
study population was predominantly male population. In a similar study
conducted by Ravi Pathiyil Shankar et al (2003) [15] also noted that majority of
patients  were  males.  Age  wise  distribution  was  analysed  and  found  that  most  of
the prescription were in the age group of 61-80 years followed by 41-60 years.
Similar study conducted by Mujtaba Hussain et al (2014) [8] also found that most
of prescription were in age group of 46-60 years. In the present study,
categorization based on co morbid conditions was analysed and found that most of
the patients were having gastrointestinal disorders which was similar to a study
conducted by Mohanraj Rathinavelu et al (2015)[2]  who reported that majority
of patients had urinary tract infection.
 The current study reports on major class of antibiotics prescribed among
patients were Cephalosporins followed by Penicillins. This study was similar to a
study conducted by Venu Gopal D et al (2014)[6] also found that cephalosporins
were mostly prescribed to inpatients and Penicillin usage was found to be
maximum in outpatients. The most commonly prescribed antibiotic was
piperacillin / tazobactum (40.6%) followed by ceftriaxone (24.6%) during the
hospital stay which could be compared to a  similar study conducted by
Meher B. R et al (2014)[9]. During the study most of the prescription had single
antibiotics prescribed (48.6%), which was similar to a study conducted by
R Selvaraj et al (2015)[1].
The current study reports that majority of the antibiotics were prescribed
for BPI, which was similar to a study conducted by Ravi Pathiyil Shankar et al
(2003)[15] also found that most of patients were prescribed antibiotics for BPI.
Reports on therapeutic outcomes during the hospital stay shows that 49%
of the patients were completely cured by the therapy and about 45 % of the
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patients showed controlled response on therapy and around 6% of the patients had
no  improvement.   A  similar  study  was  observed  by Shalem Lakkepogu et al
(2014)[40] also noted majority of patients were cured and only some patients didn’t
show any response.
The reports on number of antibiotics prescribed and duration of stay was
found statistically significant (p= 0.015). A similar study conducted by
Aparna Williams et al (2011)[47] also compared number of antibiotics prescribed
with gender, age and duration of treatment and revealed that there was statistically
significance between number of antibiotics prescribed and duration of stay in
hospital.
In the present study DDD/100 bed – days of the 10 most common
antibiotics was calculated. The antibiotic use was found to be 0.7461 DDD/ 100
beds- days and the drug piperacillin/tazobactum use was high as the dose of this
drug  used  in  our  hospital  site  was  high  when  compared  to  WHO  recommended
DDD. Our study was compared with the study conducted by Mohanraj
Rathinavelu et al(2015)[2] analysed DDD/100 bed- days and ATC code of 10
commonly used antibiotics was calculated and the drug Nitrofurantoin use was
high as the dose of this drug used in study site was high when compared to WHO
recommended DDD.
The organisms commonly seen in the study were Kbleseilla pneumoniae,
followed by E.coli, Enterococcus Faecalis  and Streptococcus aureus  which were
similar to the study conducted by Ravi Pathiyil Shankar et al (2003)[15] were the
most common organism isolated was H. Influenzae, E. coli, K. pnemoniae,
S.aureus.In  the  present  study  inorder  to  analyse  the  sensitivity  pattern  of
antibiotics,   specimen  samples  used  in  the  culture  consist  of  Sputum,  Urine,
Blood, Tracheal Culture and Pus. The sensitivity pattern of the antibiotics were
analysed and the reports were found to be similar with the study conducted by
Bijoy Thomas et al (2014)[24] for reporting antibiotics sensitivity pattern using
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urine, trachea, pus, sputum, throat swab. In a similar study conducted by Bijoy
Thomas et al (2014)[24] the sensitivity pattern data revealed that E. coli were
highly sensitive to Amikacin, followed by Klebsiella to Amikacin, and
Pseudomonas to Meropenem
In the present study 12 ADRs were observed. On gender wise distribution
the study revealed that the adverse drug reactions are found to be more prone
among male patients. In study conducted by M. Shamna et al (2014)[7] also found
males were more predominant than females in ADR occurrence. In the present
study most of adverse drug reactions (ADR) were at an age group of 61-80 years
(41.6%). A similar study conducted by Farhan Ahmad Khan et al (2013) [50] also
found that most of ADR were reported in age group of 61-80 years. The current
study showed that majority of ADR were reported in antibiotic class of Pencillins
which was similar to a study conducted by Kavita Dhar et al (2015)[51] noted that
most ADR were reported by ceftriaxone and therapeutic Class of Antibiotics
Implicated to cause ADR were beta lactams.
An assessment of ADR by WHO causality assessment scale showed both
probable and possible ADR among the patients which was similar to a study
conducted by Kavita Dhar et al (2015) [51] also  showed  that  majority  of  ADR
were probable and possible commonly seen ADR in the study were
Thrombophlebitis and Itching which was similar to a study conducted
by R. Priyadharsinai et al (2011)[49] observed rashes and urticaria as most
commomly seen ADR pattern in their study. In the present study all ADR among
the patients were fully recovered during the hospital  stay which was similar to a
study conducted by D.Yadav et al (2015) [48] also noted that most patients were
recovered.
In the present study cost of antibiotics prescribed and cost of alternate
antibiotics were calculated. The total cost was Rs. 1945.29±2175.39 for the
prescribed antibiotics whereas for alternate antibiotics the cost was
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Rs. 1169.63±1282.04. In comparison to gender, males had more cost for
antibiotics than females. Cost of antibiotics was also compared with age and
duration of stay and by comparing mean value of cost and alternate of antibiotics,
latter had less cost than former antibiotics prescribed, which could be compared
with a study conducted by Aparna Williams et al (2011)[47] the average cost  of
the antibiotics was Rupees 1995.08 (± SD 2099.99) per patient and antibiotics
expenditure accounted for 73.2% of the total drug cost.
The study on the drug interactions shows that 63.3% of prescriptions had
moderate drug interactions followed by major and minor interactions.
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CONCLUSION
The current study could assess the prescribing pattern of antibiotics,
pattern of antibiotic sensitivity, adverse effects of antibiotics prescribed and cost
comparison of antibiotics. Most commonly prescribed antibiotic in the study
population was Piperacillin / tazobactum followed by Ceftriaxone. The antibiotic
sensitivity pattern revealed that Klebsiella pneumonia was highly sensitive to
Amikacin  and  Imipenem,  E.  coli  was  sensitive  to  Piperacillin/  tazobactum,
Enterococcus faecalis was sensitive to Piperacillin/ tazobactum, Gentamycin and
Ofloxacin, Streptococcus aureus was sensitive to Imipenem, Meropenam and
Ceftriaxone. The commonly observed ADR in the study population were
Thrombophlebitis, Eosinophilia, Constipation, Itching, Haemolytic anaemia,
Vomiting, Giddiness, Abdominal pain, Haemolytic Uraemia and decreased
potassium level, these ADR’s can be prevented by proper monitoring during drug
administration and through educating the healthcare professionals regarding
commonly occurring ADR’S. The cost analysis reports that the cost of prescribed
antibiotics was high which costed Rs. 1945.29±2175.39 and which can be reduced
by prescribing alternate antibiotics at a lower cost at Rs. 1169.63±1282.04 which
would help in minimising the patient’s expenditure.  The drug interactions can be
minimized by screening the prescription with micromedex drug database before
dispensing.
Clinical pharmacists and Clinicians need to play vital role in minimizing
the antibiotic problems by conducting continual awareness programs regarding
up-to-date prescribing guidelines in the hospital and also minimizing the antibiotic
resistance. The active participation of clinical Pharmacists in the clinical ward
rounds and documentation of Pharmacist observation on prescription in patient
folder is highly recommended for safety and drug monitoring.
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Also physicians must have a clear understanding of rational therapeutic
use of antibiotics. They must be aware of the prevalence of various pathogens and
resistance patterns in their hospital and exercise good judgment in selection of the
antibiotic regimens. Irrationality can be addressed by use of guidelines,
educational activities and surveillance at all level of health care. So, measures
should be taken to avoid the inappropriate use of antibiotics.  Drug utilization
review programme must be carried out to study the rational use of antimicrobials.
The rational use of antimicrobial agents is one of the main contributors to
control worldwide emergence of antibacterial resistance, side effects and reduced
cost of the treatment.
Future Outlook
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FUTURE OUTLOOK
Antibiotics are considered as a powerful and effective drugs in fighting
against infectious diseases caused by bacteria and have been frequently used for
decades worldwide for effective treatment of a variety of bacterial infections.
Drug utilization evaluation provides insight into the efficiency of drug use, i.e.
whether a certain drug therapy provides value for money and the results of such
research are used to help to set priorities for the rational allocation of health care
budgets.
The implementation of proper screening programmes would actually help
in overcoming and reducing the risk of adverse drug reaction as well as antibiotic
resistance among patients. Clinical pharmacists and other medical professionals
need to play vital role in minimizing the antibiotic problems by conducting
continual awareness programs regarding up-to-date prescribing guidelines in the
hospital and also minimizing the antibiotic resistance. The active participation of
clinical Pharmacists in the clinical ward rounds and documentation of Pharmacist
observation on prescription in patient folder is highly recommended for safety and
drug monitoring.
The awareness of the prevalence of various pathogens and resistance
patterns in the hospitals and exercising good judgment in selection of the
antibiotic regimen by the physicians would help a lot in overcoming the problem
regarding  the  irrational  use  of  antibiotics.  The  rational  use  of  antibiotics  can  be
improved by restricting the use of antibiotics based on guidelines laid by
concerned health organisations and those guidelines should be regularly reviewed
and regular updated whenever necessary. The study seeks to monitor, evaluate and
suggest modifications in prescribing habits so as to make medical care rational
and cost effective.
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